Oridion Systems Ltd., a company out of Jerusalem, Israel, has received FDA 510(k) approval to market the firm’s Capnostream 20 CO2 Monitor with Integrated Pulmonary Index™.
Features from the product page and the press release:
The Integrated Pulmonary Index™, the latest Oridion Smart Capnography™ initiative, utilizes sophisticated algorithms to integrate the real time measures and interactions of four complex parameters – end tidal CO2 (EtCO2), respiration rate, pulse rate and SpO2 (oxygen saturation) into a single index value. The result is displayed on a scale from 1 10, where 10 indicates optimal pulmonary status.
By using the Integrated Pulmonary Index™, clinicians can quickly and easily assess a patient’s ventilation status and monitor a patient’s changing condition, thus facilitating more timely interventions to reduce patient risk and improve outcomes.
Dual parameter monitor
Supports the current standard of care providing CO2 and a compatible range of SpO2 technologies and sensors
Simple user interface with color screen
Routine functions are accessed with 2 clicks
72 hour trends
Review patient history
Compare events and medication administration to changes in patient status
Keeps you in touch with the status of your patients
Convenient bedside documentation
We think that such a device might come in handy for a variety of clinical settings, such as monitoring of patients during office-based anesthetics, recovery room monitoring, anesthesia in endoscopy suits, etc.
Press release: Oridion Receives FDA 510(k) Clearance for Capnostream™ 20 Monitor with Integrated Pulmonary Index …
Product page: The Capnostream™ 20 …